The CA 19 9 Test is an in vitro diagnostic test used to detect the presence of the carbohydrate antigen 19 9 in the blood. It is used to help diagnose and monitor certain types of cancer, including pancreatic, colorectal, and gastric cancer. The test is also used to monitor the effectiveness of cancer treatments. The CA 19 9 Test market is a subset of the larger in vitro diagnostics market. It is a highly competitive market, with a variety of companies offering different types of tests. Companies in the market include Abbott, Roche, Siemens, and Beckman Coulter. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
